Detalles de la búsqueda
1.
Retraction Note: Progesterone receptor assembly of a transcriptional complex along with activator protein 1, signal transducer and activator of transcription 3 and ErbB-2 governs breast cancer growth and predicts response to endocrine therapy.
Breast Cancer Res
; 25(1): 133, 2023 Nov 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37919764
2.
Invasive micropapillary carcinoma of the breast overexpresses MUC4 and is associated with poor outcome to adjuvant trastuzumab in HER2-positive breast cancer.
BMC Cancer
; 17(1): 895, 2017 12 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-29281999
3.
Progesterone receptor assembly of a transcriptional complex along with activator protein 1, signal transducer and activator of transcription 3 and ErbB-2 governs breast cancer growth and predicts response to endocrine therapy.
Breast Cancer Res
; 15(6): R118, 2013 Dec 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-24345432
4.
Emerging Targeted Therapies for HER2-Positive Breast Cancer.
Cancers (Basel)
; 15(7)2023 Mar 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-37046648
5.
Cancer immune exclusion: breaking the barricade for a successful immunotherapy.
Front Oncol
; 13: 1135456, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37284199
6.
Corrigendum: FXYD5/Dysadherin, a biomarker of endometrial cancer myometrial invasion and aggressiveness: its relationship with TGF-ß1 and NF-κB pathways.
Front Oncol
; 13: 1322204, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38322279
7.
Blocking soluble TNFα sensitizes HER2-positive breast cancer to trastuzumab through MUC4 downregulation and subverts immunosuppression.
J Immunother Cancer
; 11(3)2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36889811
8.
Halting ErbB-2 isoforms retrograde transport to the nucleus as a new theragnostic approach for triple-negative breast cancer.
Cell Death Dis
; 13(5): 447, 2022 05 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35534460
9.
Expanding spectrum, intrafamilial diversity, and therapeutic challenges from 15 patients with heterozygous CARD11-associated diseases: A single center experience.
Front Immunol
; 13: 1020927, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36405754
10.
Harnessing Tumor Necrosis Factor Alpha to Achieve Effective Cancer Immunotherapy.
Cancers (Basel)
; 13(3)2021 Feb 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33540543
11.
Comprehensive Identification of Pathogenic Gene Variants in Patients With Neuroendocrine Disorders.
J Clin Endocrinol Metab
; 106(7): 1956-1976, 2021 06 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-33729509
12.
Tumor Necrosis Factor α Blockade: An Opportunity to Tackle Breast Cancer.
Front Oncol
; 10: 584, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32391269
13.
Blockade of Stat3 oncogene addiction induces cellular senescence and reveals a cell-nonautonomous activity suitable for cancer immunotherapy.
Oncoimmunology
; 9(1): 1715767, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32064174
14.
FXYD5/Dysadherin, a Biomarker of Endometrial Cancer Myometrial Invasion and Aggressiveness: Its Relationship With TGF-ß1 and NF-κB Pathways.
Front Oncol
; 9: 1306, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31867269
15.
Correction: Halting ErbB-2 isoforms retrograde transport to the nucleus as a new theragnostic approach for triple-negative breast cancer.
Cell Death Dis
; 14(12): 833, 2023 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38102106
16.
TNFα-Induced Mucin 4 Expression Elicits Trastuzumab Resistance in HER2-Positive Breast Cancer.
Clin Cancer Res
; 23(3): 636-648, 2017 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27698002
17.
Juvenile exposure to a high fat diet promotes behavioral and limbic alterations in the absence of obesity.
Psychoneuroendocrinology
; 72: 22-33, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27337091
18.
Progesterone-induced stimulation of mammary tumorigenesis is due to the progesterone metabolite, 5α-dihydroprogesterone (5αP) and can be suppressed by the 5α-reductase inhibitor, finasteride.
J Steroid Biochem Mol Biol
; 149: 27-34, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25595041
19.
Heregulin Co-opts PR Transcriptional Action Via Stat3 Role As a Coregulator to Drive Cancer Growth.
Mol Endocrinol
; 29(10): 1468-85, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26340407
20.
p42/p44 MAPK-mediated Stat3Ser727 phosphorylation is required for progestin-induced full activation of Stat3 and breast cancer growth.
Endocr Relat Cancer
; 20(2): 197-212, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23329648
Resultados
1 -
20
de 20
1
Próxima >
>>